Skip page top navigation FDA Logo--links to FDA home
page Logo of and Link to start page of Office of Regulatory Affairs, 
U.S. Food and Drug Administration U.S. Food and Drug Administration Office of Regulatory Affairs HHS Logo and link to Department of Health and Human Services website

FDA Home Page | Federal-State | Import Program | Compliance | Inspection | Science | ORA Search

IA #57-16 - 6/13/01, IMPORT ALERT #57-16, "DETENTION WITHOUT PHYSICAL
EXAMINATION OF PURIFIED UROKINASE POWDER FROM CHINA OR OTHER FOREIGN SOURCES"



TYPE OF ALERT:      Detention Without Physical Examination

               NOTE:     This import alert represents the Agency's current
               guidance to FDA field personnel regarding the manufacturer
               (s) and/or product(s) at issue.  It does not create or
               confer any rights for or on any person, and does not operate
               to bind FDA or the public.

PRODUCT:       Urokinase, purified powder

PRODUCT CODE:  57YY-99, 57AY-18

PROBLEM:       Misbranded drug

PAF:           LBL-Labeling

PAC:           41R800

COUNTRY:       See Attachment

MANUFACTURER/
SHIPPER:       See Attachment

CHARGE:        "The article is subject to refusal of admission pursuant to
               section 801(a)(3) in that it appears to be misbranded in
               that its labeling lacks adequate directions for use.
               [Misbranding, Section 502(f)(1)]."

RECOMMENDING
OFFICE:        CBER, Office of Compliance and Biologics Quality, Division
               of Case Management, HFM-610

REASON FOR ALERT:   It has recently come to CBER's attention that some bulk
                    shipments of unapproved Urokinase purified powder identified
                    either as a "sample for testing only" or as a "sample"
                    entered the U.S. where it was repackaged, relabeled, and
                    sold to a pharmacy. The pharmacy used the material to
                    manufacture a new drug for human use and distributed the
                    drug. There are currently no approved foreign sources of
                    urokinase purified powder.

GUIDANCE:      Districts may detain without physical examination Urokinase
               from the firms identified on the attachment to this alert.

               Surveillance of Urokinase from other unapproved sources is
               warranted.

               Districts encountering imported, purified Urokinase powder
               should contact OCBQ/DCM, Import/Export Staff at (301)827-
               6201.

               For questions or issues concerning science, science policy,
               sample collection, analysis, preparation, or analytical
               methodology, contact the Division of Field Science at (301)
               827-7605.

PRIORITIZATION
GUIDANCE:      N/A

FOI:                No purging is required.

KEY WORDS:          Urokinase purified powder, Urokinase, biologic

PREPARED BY:   Stella Notzon, DIOP, (301) 443-6553

DATE LOADED INTO FIARS:  July 13, 2001
                ATTACHMENT TO IMPORT ALERT #57-16

               FIRMS RECOMMENDED FOR DWPE, 6/13/01

Guangdong Techpool/Biochemical Pharmaceutical Co. Ltd. (GTBP)
12 Jianzhong Road
Tianhe Hightech IND/L PK
Guangzhou, China 510630
FEI # 3002548605

Luye Pharmaceutical Co., Ltd.
[aka Shandong Luye Pharmaceutical Group Co., Ltd. or Yantai Luye
Pharmaceutical Co. Ltd]
No. 9 Baoyuan Rd., Yantai High-Tech Industrial Development Zone
(APEC Industrial Park)
Laishan District
Yantai, Shandong, China 264003
FEI # 3003153176